Specificity of HIV inhibition by modified antisense oligonucleotides.
Abramova
T
T
Institute of Bioorganic Chemistry, Novosibirsk, USSR.
Blinov
V
V
Vlassov
V
V
Gorn
V
V
Zarytova
V
V
Ivanova
E
E
Konevets
D
D
Plyasunova
O
O
Pokrovsky
A
A
Sandakhchiev
L
L
D000998:Antiviral Agents / Q000378:metabolism / Q000494:pharmacology*; D002460:Cell Line; D006678:HIV / Q000187:drug effects* / Q000502:physiology; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D015498:HIV-2 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008055:Lipids; D013329:Structure-Activity Relationship; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D008055:Lipids